CIBC Bancorp USA’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273M Sell
544,854
-100,157
-16% -$48.1M 0.33% 67
2026
Q1
$317M Buy
+645,011
New +$350M 0.43% 52
2025
Q3
$25.3M Buy
+52,093
New +$24.2M 0.14% 114

Other funds holding TMO

CIBC Bancorp USA's TMO Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q2 2026, selling an estimated $48.1M and leaving 544,854 shares worth $273M. The position accounts for 0.33% of the portfolio, ranked #67.

CIBC Bancorp USA first reported a position in TMO in Q3 2025 and has held it in 3 quarters since. The position peaked at $317M in Q1 2026. 2,508 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • CIBC Bancorp USA held 544,854 shares of Thermo Fisher Scientific worth $273M as of Q2 2026.
  • CIBC Bancorp USA sold 100,157 Thermo Fisher Scientific shares in Q2 2026, an estimated $48.1M.
  • Thermo Fisher Scientific made up 0.33% of CIBC Bancorp USA's portfolio in Q2 2026, its #67 holding.
  • CIBC Bancorp USA first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Thermo Fisher Scientific position peaked at $317M in Q1 2026.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.